Vitafoods Europe was held two weeks ago in Geneva, specifically in Palexpo. Although the results of the fairs of ingredients of the nutraceutical industry are always seen in the medium and long term, we can consider this trade show as very positive for Monteloeder.
Monteloeder has coined the concept of “Digital Nutraceutical”, which combines food & nutrition supplements with digital technology, resulting in a complete, personalized health solution.
Monteloeder is once again present in this edition of Vitafoods Europe, The global nutraceutical event, on May 15th – 17th. Do not miss this event that will take place at the Palexpo, Geneva, Switzerland.
Today I came across with 2 studies published in high-impact factor journals [Cell group] giving opposite messages regarding the use of dietary supplements, due to unexpected interactions and influences on health conditions.
– A positive effect of Nicotinamide mononucleotide (NMN), a molecule used in supplements for active aging since many years, on improving blood vessels functionality of old mice (comparable to 70-year-old humans), being a decline in capillary density and blood flow a major cause of mortality and morbidity. Interestingly, the molecular mechanism behind (that increased levels of the anti-aging enzyme SIRT1) is similar to workout and dietary restriction
– A negative effect of chondroitin-4-sulfate (CHSA), a natural glycosaminoglycan approved as a dietary supplement used for osteoarthritis, that selectively promotes the tumor growth of melanoma cells containing a specific genetic characteristic (mutation V600E of the gene BRAF) which is present in around 50% of melanomas. Not only this, it seems that it confers drug resistance to a commonly used anti-melanoma therapy (BRAF inhibitors).
Of course, these are only two examples of many studies regarding the (sometimes unpredicted) interactions between the use of supplements and health/disease conditions unrelated to their first indications. Dietary supplements contain a variety of ingredients, both natural herbal/botanicals and other categories (such as vitamins, minerals, amino acids), and in any case, it is important to understand their effects and effectiveness, because “natural” does not always mean “harmless” and “safe”1. It is actually very important to understand the label instructions, follow the healthcare providers advice (and tell them about any supplement you are taking) and trust only products with clear label statements and only from trusted manufacturers.
In the pursuit of effectiveness and safety, the healthcare trend towards Personalization will be relevant also in the Supplements field where an accurate and solid scientific background is necessary and must be always kept in mind along any step of product design and buyer journey. Indeed, a more comprehensive approach that takes into account not only the properties of any ingredient but also the eventual effects in different contexts is the safest and effective solution.
For example, as in the case of CHSA dangerous effect for a specific group of cancer patients, Genotype is an important piece of information to be considered to personalize both therapeutic treatments and dietary advice. However, it is reasonable to look for genetic information only if the “Biological plausibility” could apply: “a gene–environment interaction will only be accepted if it can be reproduced in two or more studies and also seems plausible at the biological level” [https://bit.ly/2pFwdjM]
The success of any Personalization approach resides in the use of a combination of any relevant information, as personal characteristics (genetics, age, anthropometrics, health status, family history) and context information, and never prioritizes any of them in isolation. I am confident that many relevant success stories, based on Personalization in wellbeing and healthcare, are coming and each one of us will be witness or main player in one or many of them!
Elisa Guida, PhD
Brand and Account Manager
In an article from Malaysia local newspaper, 13.3 percent of the population is facing obesity while 38.5 percent are considered overweight. Bad dietary habit is the root cause of this problem. If one is looking closer to a very typical meals options for individual, it is not difficult to understand why.
We are pleased to announce that Monteloeder has been nominated as Finalist in the “Editor’s Award for Innovation” for the Nutraingredients Awards in Vitafoods Europe, held in Geneva on May 15-17. Over 20,000 attendees are expected to visit the meeting, making it one of the largest in Europe.
Besides exhibiting, we will provide a presentation for the award entitled: “Digital Nutraceutics, the Paradigm Shift: Metabolaid; a Case Study.” Here, we will explain Monteloeder’s digitalization approach in the nutraceutical sector. Monteloeder is quickly becoming a reference in digital health, with products that are currently available combining supplementation and digitization, such as Nutroxsun and more recently Metabolaid. Specifically, Metabolaid will be presented in the meeting, which is an ingredient that has been clinically proven to help consumers lose weight by helping them control their appetite.
The winners of the awards will be announced on May 16th, during the Awards Dinner.
We thank Vitafoods Europe for our candidacy to the Award. Hope to see you there!
The last day January 22nd, an agreement was signed for the clinical trial of the MetabolAid H2020 project, an SME instrument between Monteloeder and the Universidad Católica de Murcia (UCAM).
Yesterday, Monteloeder presented at a press conference at the University Miguel Hernandez in Elche, the distinction granted by the European Commission (project EU_H2020) for the launching and marketing MetabolAid, an ingredient that provides the solution for Metabolic Syndrome.
Monteloeder would like to thank Mr. Marco Cecchetto (Project Adviser European Commission); Magnífico Mr. D. Jesús Tadeo Pastor (Rector of the UMH); Mr. Manuel Jordá (Vice-rector for Investigation and Innovation of the UMH); and Sr. Vicente Micol (Vice-rector for International Relations of the UMH) for assisting to the press conference.
In addition, the owner of a business Monteloeder, Sr. Ignacio Cartagena and Arturo Lizón Ph.D. (CEO of Monteloeder), as representatives of the company.
Moreover, we would like to thank the media support because we had a massive participation of the mass media, which picked the story up:
-Diario Información: Un freno natural contra la obesidad
OVERVIEW OF THE PRESS CONFERENCE